42 U.S.C. § 284s — Tick-borne diseases

submitted 10 years ago by Pub. L. 114-255 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 636 words · no verdicts yet

in plain englishAI-generated · not legal advice

The Secretary must keep supporting research on vector-borne diseases, including tick-borne diseases, and report on it every three years. The Secretary must also run a Tick-Borne Disease Working Group of federal and non-federal experts to review efforts and set research priorities. Within two years of December 13, 2016, and every two years after, the Working Group must report to Congress; it ends six years after that date.

(a) In general. The Secretary of Health and Human Services must keep conducting or supporting epidemiological, basic, translational, and clinical research on vector-borne diseases, including tick-borne diseases. (b) Reports. The Secretary must make sure each triennial report required by section 283 (as amended) includes information on what NIH has done under subsection (a) about tick-borne diseases. (c) Tick-Borne Diseases Working Group. (1) The Secretary must set up a Tick-Borne Disease Working Group of federal and non-federal experts, to review HHS's tick-borne-disease efforts, help agencies coordinate and avoid overlapping work, and examine research priorities. (2) The Working Group must: (A) within 2 years of December 13, 2016, build or update a summary of ongoing tick-borne research (causes, prevention, treatment, surveillance, diagnosis, and more), research advances, federal activities, research gaps, its own meetings, and public comments received; (B) recommend to the Secretary any changes or improvements needed; and (C) get input from states, localities, and outside groups — including patients, providers, researchers, and industry — on scientific advances, research questions, surveillance, and emerging pathogen strains. (3) The Working Group's members must represent diverse disciplines and views: (A) 7 federal members, from the Office of the Assistant Secretary for Health, the FDA, the CDC, NIH, and other HHS offices the Secretary picks; and (B) 7 non-federal public members: physicians treating tick-borne diseases, scientists or researchers, patients and family members, nonprofit patient-advocacy groups, and other experts the Secretary decides are useful. (4) The Working Group must meet at least twice a year. (5) Within 2 years of December 13, 2016, and every 2 years after that (until the Group ends), it must: (A) send a report on its activities and recommendations to the Secretary and two named congressional committees; and (B) post that report publicly on HHS's website. (6) The Working Group is treated as an advisory committee under the Federal Advisory Committee Act. (7) The Working Group ends automatically 6 years after December 13, 2016.

the actual law source: uscode.house.gov ↗public domain

(a) In general

The Secretary of Health and Human Services (referred to in this section as “the Secretary”) shall continue to conduct or support epidemiological, basic, translational, and clinical research related to vector-borne diseases, including tick-borne diseases.

(b) Reports

The Secretary shall ensure that each triennial report under section 283 of this title (as amended by section 2032) includes information on actions undertaken by the National Institutes of Health to carry out subsection (a) with respect to tick-borne diseases.

(1) Establishment

The Secretary shall establish a working group, to be known as the Tick-Borne Disease Working Group (referred to in this section as the “Working Group”), comprised of representatives of appropriate Federal agencies and other non-Federal entities, to provide expertise and to review all efforts within the Department of Health and Human Services related to all tick-borne diseases, to help ensure interagency coordination and minimize overlap, and to examine research priorities.

(2) Responsibilities

The working group shall—

(A)

not later than 2 years after December 13, 2016, develop or update a summary of—

(i)

ongoing tick-borne disease research, including research related to causes, prevention, treatment, surveillance, diagnosis, diagnostics, duration of illness, and intervention for individuals with tick-borne diseases;

(ii)

advances made pursuant to such research;

(iii)

Federal activities related to tick-borne diseases, including—

(I)

epidemiological activities related to tick-borne diseases; and

(II)

basic, clinical, and translational tick-borne disease research related to the pathogenesis, prevention, diagnosis, and treatment of tick-borne diseases;

(iv)

gaps in tick-borne disease research described in clause (iii)(II);

(v)

the Working Group’s meetings required under paragraph (4); and

(vi)

the comments received by the Working Group;

(B)

make recommendations to the Secretary regarding any appropriate changes or improvements to such activities and research; and

(C)

solicit input from States, localities, and nongovernmental entities, including organizations representing patients, health care providers, researchers, and industry regarding scientific advances, research questions, surveillance activities, and emerging strains in species of pathogenic organisms.

(3) Membership

The members of the working group shall represent a diversity of scientific disciplines and views and shall be composed of the following members:

(A) Federal members

Seven Federal members, consisting of one or more representatives of each of the following:

(i)

The Office of the Assistant Secretary for Health.

(ii)

The Food and Drug Administration.

(iii)

The Centers for Disease Control and Prevention.

(iv)

The National Institutes of Health.

(v)

Such other agencies and offices of the Department of Health and Human Services as the Secretary determines appropriate.

(B) Non–Federal public members

Seven non–Federal public members, consisting of representatives of the following categories:

(i)

Physicians and other medical providers with experience in diagnosing and treating tick-borne diseases.

(ii)

Scientists or researchers with expertise.

(iii)

Patients and their family members.

(iv)

Nonprofit organizations that advocate for patients with respect to tick-borne diseases.

(v)

Other individuals whose expertise is determined by the Secretary to be beneficial to the functioning of the Working Group.

(4) Meetings

The Working Group shall meet not less than twice each year.

(5) Reporting

Not later than 2 years after December 13, 2016, and every 2 years thereafter until termination of the Working Group pursuant to paragraph (7), the Working Group shall—

(A)

submit a report on its activities under paragraph (2)(A) and any recommendations under paragraph (2)(B) to the Secretary, the Committee on Energy and Commerce of the House of Representatives, and the Committee on Health, Education, Labor, and Pensions of the Senate; and

(B)

make such report publicly available on the Internet website of the Department of Health and Human Services.

(6) Applicability of FACA

The Working Group shall be treated as an advisory committee subject to the Federal Advisory Committee Act (5 U.S.C. App.).1

(7) Sunset

The Working Group under this section shall terminate 6 years after December 13, 2016.

Source credit: (Pub. L. 114–255, div. A, title II, § 2062, Dec. 13, 2016, 130 Stat. 1079.)

history & why it existsrecord from the source credit

2016Enacted · Pub. L. 114-255 · 130 Stat. 1079

A history note hasn’t been published yet. The record shows enactment by Pub. L. 114-255 on 2016-12-13.

all 0 arguments · sorted by: best

no arguments yet — make the first case